118 related articles for article (PubMed ID: 10706074)
1. Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B cell lymphomagenesis.
Duchosal MA; Fuzzati-Armentero MT; Baccala R; Layer A; Gonzalez-Quintial R; Leturcq D; Rüegg M; Trouillet P; Mauray S; Tissot JD; Schapira M
Exp Hematol; 2000 Feb; 28(2):177-92. PubMed ID: 10706074
[TBL] [Abstract][Full Text] [Related]
2. Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ.
Vallet V; Mauray S; Kindler V; Aubry D; Ruegg M; Cherpillod J; Waridel F; Schapira M; Duchosal MA
Xenotransplantation; 2005 Jan; 12(1):38-48. PubMed ID: 15598272
[TBL] [Abstract][Full Text] [Related]
3. The diversity of antigen-specific antibodies in humans and in two xenochimeric SCID mouse models.
Layer A; Tissot JD; Schneider P; Duchosal MA
Electrophoresis; 2000 Jul; 21(12):2463-75. PubMed ID: 10939460
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
5. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
6. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.
Böcher WO; Marcus H; Shakarchy R; Dekel B; Shouval D; Galun E; Reisner Y
Immunology; 1999 Apr; 96(4):634-41. PubMed ID: 10233752
[TBL] [Abstract][Full Text] [Related]
9. A promising model of primary human immunization in human-scid mouse.
Bombil F; Kints JP; Scheiff JM; Bazin H; Latinne D
Immunobiology; 1996 Aug; 195(3):360-75. PubMed ID: 8877409
[TBL] [Abstract][Full Text] [Related]
10. [Reconstitution of Hu-SCID mice transplanted with human tonsillar lymphocytes immunized with dengue virus-2 in vitro and its immune response].
Zuo L; Guo H; Zhang C
Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):597-9. PubMed ID: 9275474
[TBL] [Abstract][Full Text] [Related]
11. hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease.
Fuzzati-Armentero MT; Duchosal MA
Histol Histopathol; 1998 Jan; 13(1):155-68. PubMed ID: 9476646
[TBL] [Abstract][Full Text] [Related]
12. Distribution and engraftment patterns of human tonsillar mononuclear cells and immunoglobulin-secreting cells in mice with severe combined immunodeficiency: role of the Epstein-Barr virus.
Nadal D; Albini B; Chen CY; Schläpfer E; Bernstein JM; Ogra PL
Int Arch Allergy Appl Immunol; 1991; 95(4):341-51. PubMed ID: 1660036
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
14. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
[TBL] [Abstract][Full Text] [Related]
15. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils.
Nadal D; Albini B; Schläpfer E; Chen C; Brodsky L; Ogra PL
Clin Exp Immunol; 1991 Sep; 85(3):358-64. PubMed ID: 1893614
[TBL] [Abstract][Full Text] [Related]
17. The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides.
Chargui J; Dye D; Blomberg J; Desgranges C; Touraine JL
J Immunol Methods; 1995 Apr; 181(1):91-100. PubMed ID: 7730668
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
Front Immunol; 2018; 9():601. PubMed ID: 29628927
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
20. A rat monoclonal anti-(human CD2) and L-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome.
Bombil F; Kints JP; Havaux X; Scheiff JM; Bazin H; Latinne D
Cancer Immunol Immunother; 1995 Jun; 40(6):383-9. PubMed ID: 7627995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
